16 related articles for article (PubMed ID: 21784088)
1. PTEN in DNA damage repair.
Ming M; He YY
Cancer Lett; 2012 Jun; 319(2):125-129. PubMed ID: 22266095
[TBL] [Abstract][Full Text] [Related]
2. A multicomponent microemulsion using rational combination strategy improves lung cancer treatment through synergistic effects and deep tumor penetration.
Qu D; Guo M; Qin Y; Wang L; Zong B; Chen Y; Chen Y
Drug Deliv; 2017 Nov; 24(1):1179-1190. PubMed ID: 28841044
[TBL] [Abstract][Full Text] [Related]
3. Multinucleation regulated by the Akt/PTEN signaling pathway is a survival strategy for HepG2 cells.
Mukherjee A; Misra S; Howlett NG; Karmakar P
Mutat Res; 2013 Aug; 755(2):135-40. PubMed ID: 23796964
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of PTEN perturbs genomic stability via activation of Akt and down-regulation of Rad51 in human embryonic kidney cells.
Mukherjee A; Karmakar P
Mol Carcinog; 2013 Aug; 52(8):611-8. PubMed ID: 22488521
[TBL] [Abstract][Full Text] [Related]
5. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
6. Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells.
Han P; Li H; Jiang X; Zhai B; Tan G; Zhao D; Qiao H; Liu B; Jiang H; Sun X
Mol Oncol; 2017 Mar; 11(3):320-334. PubMed ID: 28164434
[TBL] [Abstract][Full Text] [Related]
7. PTEN enhances G2/M arrest in etoposide-treated MCF‑7 cells through activation of the ATM pathway.
Zhang R; Zhu L; Zhang L; Xu A; Li Z; Xu Y; He P; Wu M; Wei F; Wang C
Oncol Rep; 2016 May; 35(5):2707-14. PubMed ID: 26986476
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of PTEN is responsible for the survival of Hep G2 cells in response to etoposide-induced damage.
Mukherjee A; Samanta S; Karmakar P
Mutat Res; 2011 Oct; 715(1-2):42-51. PubMed ID: 21784088
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
